Vaccine Access, Certainty, and Innovation Act of 2015
Do you support it?
Want to know if it passes?
We'll email you when HR 786 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on HR 786.
You're tracking HR 786
We'll email you the moment it moves.
HR 786 — Vaccine Access, Certainty, and Innovation Act of 2015
Last action — Referred to the Subcommittee on Health.
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
✓In Committee
-
Died in session
This bill died with 114th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Vaccine Access, Certainty, and Innovation Act of 2015 This bill requires the Centers for Disease Control and Prevention (CDC) to report on the process used by the Advisory Committee on Immunization Practices (ACIP) in making recommendations on vaccines. The Department of Health and Human Services (HHS) must issue final guidance to facilitate the use of expedited pathways for the development and licensure of vaccines to prevent certain infectious diseases. The Public Health Service Act is amended to require the CDC to provide a vaccine developer, upon request, with information on public health needs and priorities and certain epidemiological analyses or data. The Federal Food, Drug, and Cosmetic Act is amended to require the Food and Drug Administration to establish a process for designating diseases as tropical diseases included in the priority review voucher program. The amount of the priority review user fee is set to the cost difference between a priority review and a non-priority review. The National Institutes of Health must support or conduct activities to advance the development of vaccines and must report on vaccine research. Within 60 business days of a recommendation by ACIP, HHS must determine whether to update Medicare coverage of vaccines. The Government Accountability Office must report on the impact of Medicare and Medicaid reimbursement rates on vaccine access. For purposes of calculating a medical loss ratio, the cost of a program to increase adult immunization is accounted for: (1) by a private health insurer as an activity that improves health care quality, and (2) by a Medicare Advantage or Part D plan under title XVIII (Medicare) of the Social Security Act as a medical loss.
Bill Text
We don't have the full text on file for this bill yet.
Read HR 786 on the official United States source →Action History
-
Referred to the Subcommittee on Health.
-
Referred to the Subcommittee on Health.
-
Referred to House Ways and Means
-
Referred to House Energy and Commerce
-
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
-
Introduced in House
Sponsors
- Renee Ellmers · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 546 not signed on
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (546)
546 members have not signed on to this bill.
Show all 546 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HR 786 do?
- Vaccine Access, Certainty, and Innovation Act of 2015 This bill requires the Centers for Disease Control and Prevention (CDC) to report on the process used by the Advisory Committee on Immunization Practices (ACIP) in making recommendations on vaccines. The Department of Health and Human Services (HHS) must issue final guidance to facilitate the use of expedited pathways for the development and licensure of vaccines to prevent certain infectious diseases. The Public Health Service Act is amended to require the CDC to provide a vaccine developer, upon request, with information on public health needs and priorities and certain epidemiological analyses or data. The Federal Food, Drug, and Cosmetic Act is amended to require the Food and Drug Administration to establish a process for designating diseases as tropical diseases included in the priority review voucher program. The amount of the priority review user fee is set to the cost difference between a priority review and a non-priority review. The National Institutes of Health must support or conduct activities to advance the development of vaccines and must report on vaccine research. Within 60 business days of a recommendation by ACIP, HHS must determine whether to update Medicare coverage of vaccines. The Government Accountability Office must report on the impact of Medicare and Medicaid reimbursement rates on vaccine access. For purposes of calculating a medical loss ratio, the cost of a program to increase adult immunization is accounted for: (1) by a private health insurer as an activity that improves health care quality, and (2) by a Medicare Advantage or Part D plan under title XVIII (Medicare) of the Social Security Act as a medical loss.
- Who sponsors HR 786?
- HR 786 is sponsored by Renee Ellmers (R).
- What is the current status of HR 786?
- This bill died with 114th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track HR 786?
- Track HR 786 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HR 786
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HR 786
Last checked for changes about 16 hours ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →